compromise. Overall, communication is important to ensure preparedness amongst all providers and patient safety. ## Review Questions - [Access free multiple choice questions on this topic.](https://www.statpearls.com/account/trialuserreg/?articleid=132871&utm_source=pubmed&utm_campaign=reviews&utm_content=132871) - [Comment on this article.](https://www.statpearls.com/articlelibrary/commentarticle/132871/?utm_source=pubmed&utm_campaign=comments&utm_content=132871) ## References 1. Subramaniam K, Yared JP. Management of pulmonary hypertension in the operating room. Semin Cardiothorac Vasc Anesth. 2007 Jun;11(2):119-36. \[[PubMed: 17536116](https://pubmed.ncbi.nlm.nih.gov/17536116)\] 2. Pilkington SA, Taboada D, Martinez G. Pulmonary hypertension and its management in patients undergoing non-cardiac surgery. Anaesthesia. 2015 Jan;70(1):56-70. \[[PubMed: 25267493](https://pubmed.ncbi.nlm.nih.gov/25267493)\] 3. Pritts CD, Pearl RG. Anesthesia for patients with pulmonary hypertension. Curr Opin Anaesthesiol. 2010 Jun;23(3):411-6. \[[PubMed: 20386437](https://pubmed.ncbi.nlm.nih.gov/20386437)\] 4. McGlothlin D, Ivascu N, Heerdt PM. Anesthesia and pulmonary hypertension. Prog Cardiovasc Dis. 2012 Sep-Oct;55(2):199-217. \[[PubMed: 23009916](https://pubmed.ncbi.nlm.nih.gov/23009916)\] 5. Green JB, Hart B, Cornett EM, Kaye AD, Salehi A, Fox CJ. Pulmonary Vasodilators and Anesthesia Considerations. Anesthesiol Clin. 2017 Jun;35(2):221-232. \[[PubMed: 28526144](https://pubmed.ncbi.nlm.nih.gov/28526144)\] 6. Minai OA, Yared JP, Kaw R, Subramaniam K, Hill NS. Perioperative risk and management in patients with pulmonary hypertension. Chest. 2013 Jul;144(1):329-340. \[[PubMed: 23880683](https://pubmed.ncbi.nlm.nih.gov/23880683)\] 7. Kim D, George MP. Pulmonary Hypertension. Med Clin North Am. 2019 May;103(3):413-423. \[[PubMed: 30955510](https://pubmed.ncbi.nlm.nih.gov/30955510)\] 8. Ashes C, Roscoe A. Transesophageal echocardiography in thoracic anesthesia: pulmonary hypertension and right ventricular function. Curr Opin Anaesthesiol. 2015 Feb;28(1):38-44. \[[PubMed: 25377232](https://pubmed.ncbi.nlm.nih.gov/25377232)\] 9. Olsson KM, Halank M, Egenlauf B, Fistera D, Gall H, Kaehler C, Kortmann K, Kramm T, Lichtblau M, Marra AM, Nagel C, Sablotzki A, Seyfarth HJ, Schranz D, Ulrich S, Hoeper MM, Lange TJ. Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018. Int J Cardiol. 2018 Dec 01;272S:46-52. \[[PubMed: 30190155](https://pubmed.ncbi.nlm.nih.gov/30190155)\] 10. Seferian A, Simonneau G. Therapies for pulmonary arterial hypertension: where are we today, where do we go tomorrow? Eur Respir Rev. 2013 Sep 01;22(129):217-26. \[[PMC free article: PMC9487345](/pmc/articles/PMC9487345/)\] \[[PubMed: 23997048](https://pubmed.ncbi.nlm.nih.gov/23997048)\] 11. Barnes H, Brown Z, Burns A, Williams T. Phosphodiesterase 5 inhibitors for pulmonary hypertension. Cochrane Database Syst Rev. 2019 Jan 31;1(1):CD012621. \[[PMC free article: PMC6354064](/pmc/articles/PMC6354064/)\] \[[PubMed: 30701543](https://pubmed.ncbi.nlm.nih.gov/30701543)\] 12. Ventetuolo CE, Klinger JR. Management of acute right ventricular failure in the intensive care unit. Ann Am Thorac Soc. 2014 Jun;11(5):811-22. \[[PMC free article: PMC4225807](/pmc/articles/PMC4225807/)\] \[[PubMed: 24828526](https://pubmed.ncbi.nlm.nih.gov/24828526)\] **Disclosure:** Hassam Zulfiqar declares no relevant financial relationships with ineligible companies. **Disclosure:** Brianna Granlund declares no relevant financial relationships with ineligible companies.